SOAT1 and cancer: Despite these beneficial functions of IL-6, dysregulated IL-6-induced signalling (e.g. hyper-activation of JAK/STAT signalling) contributes to the development of pathologies such as autoimmune diseases, chronic inflammation, or even cancer.